[Skip to the guide](#main) Before choosing care, make room for questions. [Make your list ](/questions) [Licensed Peptide Doctor](/) License lookups for prescribers, question by question. Gives no medical care. Check a prescriber [License lookup](/license) [Online visits](/online) Check the medicine [Medicine status](/medicine) [Pharmacy checks](/pharmacy) [Cautions](/safety) Prepare for care [Cost and coverage](/cost) [Questions to take](/questions) [Source reading](/sources) # Cautions before choosing care Ask what is being proposed, who will answer concerns, and where to turn when a question needs personal medical help. [Read the answer](#answer) ## When the question is urgent For severe allergic-reaction symptoms, get emergency help by calling 911, as MedlinePlus directs. [Read the urgent-help signs ](#urgent-symptoms-and-help) Questions about care [Checking a license](/license) [The medicine offered](/medicine) [An online visit](/online) [Checking the pharmacy](/pharmacy) [The full cost](/cost) [Cautions to read](/safety) [Questions to take](/questions) [Public source reading](/sources) ## Urgent symptoms and help A severe allergic reaction may involve breathing or swallowing trouble, or a swollen face or tongue. For severe allergic-reaction symptoms, get emergency help by calling 911, as MedlinePlus directs. Anaphylaxis is the medical name for a life-threatening allergic reaction; it can develop within seconds or minutes. ## Pause at a claim that skips the assessment For a service you are still considering, ask how the prescriber will learn about your concern and discuss options. Ask how you can raise something the intake form did not cover. The state-board group’s guidance adopted in May 2026 rejects prescribing based only on a person’s choice from a treatment menu. That is board guidance rather than a single national law; state rules govern the specific visit. Ask which gaps might prompt more assessment or a decision against the plan. Be ready to discuss a different direction if the reply raises another concern. ## Look past reassuring product language A medicine prepared to order involves the process called compounding. For product claims, the federal reviewer is FDA, the Food and Drug Administration. These compounded medicines had no FDA approval at the September 2026 check. Before marketing, FDA had not reviewed their safety, the quality of the preparation, or how well it works. Preparation matters for the actual medicine. With poor compounding, germs or other contamination may get in, and the amount of the working ingredient may be too high or low. In letters to peptide sellers, FDA warned that injections bypass some body defenses against germs and toxins and can cause serious harm. Those letters describe the agency’s concerns about sellers’ products; they do not establish how often a problem occurs for an individual medicine. Ask for the product information and a discussion of its cautions. Do not fill gaps with a claim that the whole peptide category is safe. ## Keep product instructions specific Storage depends on the actual medicine: some peptide products need refrigeration, while others have room-temperature instructions. Ask the pharmacist to clarify the label for what was dispensed. If delivery or instructions raise a concern, ask for an answer about that product before relying on a general rule from the internet. FDA has received reports of errors involving compounded injectable semaglutide, including some events that required hospital care, as checked in September 2026. Bring unclear instructions directly to the prescriber or pharmacist for an answer about what was dispensed. If pregnancy, plans for pregnancy, or breastfeeding are part of your situation, raise them by name in the visit. Ask what the exact product’s information says. A compounded or other unapproved product does not come with equivalent FDA-reviewed pregnancy and breastfeeding information. ## Know where a report fits FDA’s MedWatch program accepts medical-product problem reports from the public as well as health professionals. A report can help put a concern on record. It does not replace a conversation about the care you need now. An unwanted experience during use is what FDA calls an adverse event. FDA says receiving a report does not establish the drug as its cause. Those reports cannot be used to work out how often a problem happens. When comparing an offer, keep a note of what is known, what is uncertain, and who will answer later questions. Ask about other ways to address your concern before making a commitment. ## Reading for this answer - [MedlinePlus on severe allergic reactions](https://medlineplus.gov/ency/article/000844.htm) This gives signs and the emergency-help instruction. It is not a test that can diagnose symptoms for a reader. - [FDA’s MedWatch reporting program](https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program) Use the public reporting route for a medical-product concern. A report records an experience; it does not establish its cause. ## Choose questions to ask [Continue reading](/questions) [Licensed Peptide Doctor](/) This reading guide offers questions and public record checks, with no clinic service and no medicine sales. Check a prescriber [License lookup](/license) [Online visits](/online) Check the medicine [Medicine status](/medicine) [Pharmacy checks](/pharmacy) [Cautions](/safety) Prepare for care [Cost and coverage](/cost) [Questions to take](/questions) [Source reading](/sources) © Licensed Peptide Doctor. [Text page index](/llms.txt) [Plain text for this answer](/safety.md)